Endothelial Dysfunction Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
- Transparency Market Research
Global Endothelial Dysfunction Market: Synopsis
Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and vasoconstricting substances produced by the endothelium.
Endothelium dysfunction can contribute to several disorders such as hypertension, diabetes, hypercholesterolaemia, Behcet's disease among others. Endothelium dysfunction is now regarded as an early pivotal event in atherogenesis and has been considered an important event in the development of micro vascular complications in diabetes. Nitric oxide reduction is regarded as one of the prominent features of the endothelial dysfunction. Nitric oxide has following physiological effect which contributes to the inhibition of atherosclerosis which include reduction in LDL oxidation, decrease in platelet aggregation to the endothelium, inhibition of smooth muscles cell proliferation and prevention of leukocyte adhesion and infiltration into the vessel.
Global Endothelial Dysfunction Market: Trends and Prospects
The testing and diagnosis method for endothelial dysfunction include angiography with acetylcholine injection, however due to complex and invasive nature of diagnosis till date it has never been used beyond research activities. The non-invasive method to measure endothelial dysfunction comprises percent flow mediated dilation method measured by Brachial Artery Ultrasound Imaging devices. Though the technique is simple yet the acceptance across globe is hampered due to variation in results. A negative correlation between percent flow mediated dilation and baseline artery size is recognized as a fundamental scaling problem, leading to biased estimates of endothelial function. In 2003, FDA approved device EndoPAT which works by measuring Reactive Hyperemia Index (RHI) during nits clinical trials has shown significant results and up to 80% sensitivity as compared to acetylcoline angiogram. Endothelial function can be improved significantly by exercise, smoke cessation, weight loss in overweight or obese persons, and improved diet. In past few years there has been a significant inclination by leading towards development of variety of novel drugs for treating endothelial dysfunction.
Some of the pipelined and available drugs in the market include maxacalcitol, S-adenosyl methionine, MC-1575 and paricalcitol among others. Some of the prominent drivers to the market include exponential rise in number of obese population, reduced physical activities and diabetes leading to increase in chances of acquiring cardiovascular diseases. Such factors have effectively contributed towards the growth and acceptance of variety of drugs and other therapeutics in past will continue to drive the market in forthcoming years as well. Advances in recombinant and gene therapy are also favoring the growth of endothelial dysfunction drugs uptake and can be an opportunity area for new entrants in the market.
Global Endothelial Dysfunction Market: Regional Outlook
Geographically North America and Europe market is currently the leading market for the endothelial dysfunction products due to high involvement of research and development, advanced medical facilities and broad awareness related to cardiovascular diseases and other related diseases. Lack of government interventions and funds to conduct research and development have affected the growth and revenue share for emerging and developing nations. With the substantial rise in cardiovascular and diabetic case in the Asia-Pacific and Middle East countries in upcoming years the demand for endothelial dysfunction market is likely to grow in these regions in next 5-7 years.
Global Endothelial Dysfunction Market: Key Players
Some of the key players in the market include Abbott Laboratories, Chugai Pharmaceutical Co., Ltd., Johnson & Johnson, Glucox Biotech AB, Stealth Peptides Inc. among other prominent players in the market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017